Singapore’s ClearBridge BioMedics Raises $9 Million Series B
YoungUpstarts
MARCH 13, 2013
Other investors in this financing round include SPRING Seeds Capital , Clearbridge BSA and Lu Yoh Chie of Biosensors International , and existing shareholder BioVeda. The filtered cancer cells remains alive, and can be used for further medical research as well as refining customized cancer treatment for patients.
228 
Let's personalize your content